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the Niemann-Pick C1 (NPC1) receptor, suggesting the virus has
zoonotic potential. The batswere also found roosting inside houses,
indicating the potential for human transmission. However, further
studies are required to investigate whether exposure has actually
occurred or if BOMV is pathogenic in humans.
https://doi.org/10.1016/j.ijid.2018.11.030
03.011
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Purpose: PCR and serological-based approaches have been used
to identify henipavirus and ﬁlovirus (e.g. Nipah virus, Ebola virus)
exposure or infection in bat populations in Bangladesh, China, and
Southeast Asia. Our understanding of the diversity of these viruses
in bat reservoirs, and the frequency of spillover to other animals or
people, is extremely limited. We hypothesized that henipaviruses
and ﬁloviruses were circulating within multiple bat reservoirs and
that spillover of these viruses to non-human primate populations
has occurred in Malaysia.
Methods & Materials: We utilized a multiplex serological
assay to screen sera for reactive IgGs that bound to antigens
from henipaviruses and ﬁloviruses. We produced virus attach-
ment glycoproteins (GP) from sixteen virus species in the families
Paramyxoviridae and Filoviridae. As part of our ongoing collabo-
ration, we conducted in-country assay training and sera testing at
the Department of Wildlife and National Parks, National Wildlife
Forensic Laboratory. We screened sera from eight bat genera and
sera from Macaca fascicularis populations.
Results: Sera samples from Pteropus hypomelanus (n =56) were
reactivewithNipahvirusGP (25%)andcross-reactivewithGPs from
closely-related henipaviruses. In these same P. hypomelanus sam-
ples we detected reactivity with Ebola virus and Sudan virus GPs
(10% and 5%, respectively). Sera from several Hipposideros species
and P. hypomelaus reacted with the Henipavirus species, Mojiang
virus GP. Two M. fascicularis sera samples reacted with GPs from
Ebola virus and Bundibugyo virus and M. fascicularis sera samples
speciﬁcally reacted with Mojiang virus; all four samples exhibited
median ﬂuorescence intensity values > 10,000. We also detected
reactivity to Ebola virus and Sudan virus GPs in sera samples col-
lected from Hipposideros, Cynopterus and Rhinolophus species. We
didnotdetect anysamples thatwere reactivewithRestonvirusGPs.
Conclusion:Wedetected evidence of past exposure to virus(es)
most antigenically-similar to Ebola virus, Bundibugyo virus, and
Sudan virus in sera samples from bat and non-human primate pop-
ulations collected in Malaysia. This is also the ﬁrst sero-survey for
Mojiang virus and the ﬁrst evidence of exposure to Mojiang virus
in bats and non-human primates. Our results suggest that there
are different but antigenically related henipaviruses and ﬁloviruses
circulating in bats in Malaysia.
https://doi.org/10.1016/j.ijid.2018.11.031
03.012
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Purpose: Building on prior surveillance experiences from the
Bolivian Amazon region, a new initiative aims to improve the liveli-
hood of rural communities by detecting, preventing and combating
zoonotic diseases.
Methods & Materials: A new organisational approach has been
chosen to develop sustainable health solutions for humans, domes-
tic animals, wildlife and local ecosystems in remote indigenous
communities with limited access to health services and whose ter-
ritory is being affected by anthropogenic changes. The initiative
is built on three pillars: research, capacity building and citizen
engagement and is led by a local non-proﬁt organisation, TekoKavi,
who works closely with Bolivian regional health and veterinary
authorities, laboratories anduniversities aswell as local indigenous
community organisations, health centres and schools to improve
awareness raising and building of networks and the much needed
new capacities. The project is funded by a Danish social capac-
ity building fund, and a Danish NGO-collaboration partner of Teko
Kavi and two Danish universities provide One Health and capacity
building expertise.
Sampleswere collected in 2018 from76 humans and 84 domes-
tic animals in addition to environmental and wildlife samples in
two Tacana Indigenous Territory villages in the San Buenaventura
municipality located in the Amazon region of La Paz Department,
Bolivia. Also, health information was collected for data analysis
by face-to-face interviews of the tested people and owners of the
tested animals.
Results: The results are alarming: a high proportion of partici-
pating humans in the two villages were ill with fever, muscle pain,
nauseaand fatigueamongother symptomsonor shortlyprior to the
dayof sampling.Moreover, ahighproportion (27%)ofhumanserum
samples were found to contain IgM antibodies directed against
Leptospira spp., indicative of acute infection, while 63.6% of PCR-
tests of urine samples from humans and 50% from animals were
Leptospira-positive. Besides this hitherto unreported disease in the
area, other important zoonotic pathogenswere also detected in the
samples, including Hantavirus and Aerococcus viridans.
Conclusion: Information meetings have been held in the
local communities as well as between the health institutions
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and workers, and a participatory integrated health intervention
strategy is being discussed between partners in the initiative.
https://doi.org/10.1016/j.ijid.2018.11.032
03.013
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Purpose: Hendra virus is a zoonotic pathogen which was ﬁrst
identiﬁed in 1994 and spillover events in horses were sporadic
in Queensland (QLD) and New South Wales (NSW), Australia
until 2010. The predominant differences during 2011-2017 were
the number of spillover events (46 incidents during 2011-2017
compared to 14 incidents during 1994-2010), the unprecedented
number of incidents in NSW (19 incidents during 2011-2017 com-
pared to one incident during 1994-2010) and the geographic
clustering in southeast QLD and northern NSW (30 incidents in
southeast QLD and north NSW compared to 16 incidents in cen-
tral andnorthernQLDduring2011-2017).Detailed epidemiological
investigations on infected property (IP)were conducted on all Hen-
dra virus infected horse properties during 2011-2017 to ﬁnd any
risk factors related to these spillover events and better manage-
ment recommendations for risk mitigation.
Methods & Materials: Proﬁling activities involved case his-
tory reviews, property visits and interviews with the horse
and/or property owners focusing on the infected horse(s) (health,
behaviour), husbandry (supplementary feeding, water), prop-
erty (pasture condition, paddock/yard/stable), vegetation (location
and stage of fruiting/ﬂowering trees/shrubs), ﬂying-fox activi-
ties (as evidenced by the presence of spats, faeces, partly-eaten
fruit/ﬂowers/seeds and/or infra-red/thermal camera photographs)
and potential ﬂying-fox - horse interaction site(s).
Results: Findings from IP proﬁling showed that all infected
horses were paddock horses and that ﬂying-fox activities were
identiﬁed on most infected properties even when the owners
reported no ﬂying-fox sightings. Infected property proﬁling ﬁnd-
ings also indicated the management of the horses (locations of
water/feed troughs, night yarding under ﬂowering/fruiting trees)
and horse behaviour may play a role in the Hendra virus transmis-
sion through the ﬂying-fox - horse interaction.
Conclusion: Proﬁling ﬁndings have identiﬁed several high risk
factors related to the horse and human behaviours. Horse person-
ality such as dominance and inquisitiveness could have brought
the horses closer to the environment with ﬂying –fox foraging
activities. Several human behaviours in related to the decision of
horse husbandry could have also placed the horses under higher
risk due to indirectly interaction with ﬂying-fox activities. This
results have reinforced Queensland government’s recommenda-
tions to the horse owners on Hendra virus risk management and
risk mitigation for animal and human health.
https://doi.org/10.1016/j.ijid.2018.11.033
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Purpose: Lassa fever is a major public health issue in Western
Africa and there is still no licensed vaccine. Here we have used the
Measles virus (MeV) vaccine platform to generate Lassa fever vac-
cine candidates expressing the Lassa virus (LASV) glycoprotein GPC
alone or in combination with the nucleoprotein NP or the matrix
protein Z. We have demonstrated that NP should be mutated to
preserve a strong induction of the type I IFN response and activa-
tion of human antigen presenting cells in response to the vector.
We selected two vaccines, MeV-NPmut/GPC and MeV-Z/GPC, for
further testing in non-human primates.
Methods & Materials: Cynomolgus monkeys were immunized
with a single dose of MeV-NPmut/GPC, MeV-Z/GPC, or empty MeV
vector as a control, one month before being challenged with a
lethal dose of LASV. Animals were monitored for biological, clini-
cal, virological, and immunological paramaters after immunization
and challenge.
Results: The two vectors were safe, did neither replicate in nor
shed from vaccinees, and protected all cynomolgusmonkeys while
controls all died from Lassa fever. Interestingly, MeV-NPmut/GPC
conferred almost a sterilizing immunity and animals only expe-
rienced a transient elevation in the body temperature but no
biological alterations or clinical signs. On the contrary, MeV-Z/GPC
–immunized monkeys developed more severe symptoms and a
prolongedLASVviremia. Analysis of the immune responses showed
that early and robust T cell responses against GPC are critical
for enhanced protection after challenge and suggests that T cell
immunity against NP may greatly enhance protection. Early tran-
scriptomic and proteomic studies have also been performed after
immunization to identify early biological markers correlated with
vaccine efﬁciency. MeV-based vaccines induce a strong humoral
response against MeV and could thus be used as bivalent vaccines
to prevent Lassa fever and Measles in endemic areas where both
MeV and LASV are circulating.
Conclusion: The MeV-NPmut/GPC vaccine is safe, fully pro-
tects after a single shot cynomolgus monkeys against a lethal LASV
challenge and could be used as a bivalent Measles-Lassa vaccine.
Importantly, Themis Biosciences has been selected by the Coalition
for Epidemic Preparedness Innovations (CEPI) to further develop
the MeV-NPmut/GPC vaccine and test it in phase I and II clinical
trials.
https://doi.org/10.1016/j.ijid.2018.11.034
